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Abstract
Objective: Decipher mechanisms that underlie cervical remodeling (CR) during pregnancy. Design and population: 
Examine the proteomic profile of mice cervices in early and late pregnancy and verify data generated using 
Western Blot and real time PCR analysis. Main outcome measures: Identify signature proteins. Results: In total, 
seventy three (73) signature proteins were identified and were found up regulated in pregnancy, namely proteins 
associated with: a) collagen presence and organization (4), notably biglycan and lumican, b) immune scavenging 
functions and c) cytoskeletal activity. These proteomic trends were verified through Western blot and real time 
PCR analysis. Conclusion: These signature proteins and their expression profile collectively suggest a complex 
biological process involving extracellular matrix (ECM)- and immune`-associated factors. Based on these data, we 
propose that biglycan may provide the link between natural birth and inflammation-mediated pre-term birth.
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Introduction 
The cervix undergoes highly complex biochemical and mechanical 
changes during and immediately after pregnancy [1]. This multifactorial 
process, termed cervical remodeling (CR), is divided into four distinct 
but overlapping stages, i.e., cervical softening, ripening, dilation and 
repair [2,3]. In mice, CR begins at about day 12 of a 19-day gestation, 
whereas in human it begins in the first trimester of pregnancy [2]. The 
CR alterations completely transforms the cervix from a non-pliable 
rigid structure to a flexible one, thus enabling it to perform its key 
role, notably, the retention of the rapidly growing fetus in uteri, while 
simultaneously preparing for its final passage at birth [1]. Unfortunately, 
the exact mechanisms that triggers and regulate these alterations are 
currently poorly understood. A comprehensive knowledge of this 
process (CR) is essential in managing obstetrical complications, 
such as preterm labor and cervical lacerations, which have serious 
consequences for the health of the fetus, as well as the mother [4,5]. 
Because of the complex nature of CR and involvement of multiple 
factors, which have in-built redundancies, there is need to use a variety 
of techniques that vary in scope and sensitivity, such as proteome-wide 
techniques in combination or addition to the reductionist approaches 
that focus on a single gene or protein at a given time, which has been 
the predominant and historical approach. Such robust techniques could 
shed more light on this complex process and perhaps help resolve the 
current debates on the two competing models for term-birth [6,7]. 
In the early 1980s, Mont Liggins proposed a model that inflammatory 
cells induce changes in the cervical extracellular matrix that lead to 
cervical ripening [8], although the proposed mechanism as a model 
for all parturition was questioned earlier on, suggesting that preterm 
and term had differing biochemical triggers [9,10]. The Liggins model 
accounts for the increased incidence of preterm delivery in women with 
inflammatory diseases [5,11] and has been the dominant model, until 
very recently [12-14]. While the Liggins model certainly explains the 
increased prevalence of preterm birth in women with inflammatory 
diseases, such as chorioamnionitis, only less than half of all pre-term 
births can be linked to an inflammatory disease or condition [11]. 
More recent studies support the idea that while inflammation may 
cause parturition in certain circumstances, it (inflammation) is not 
involved in natural physiologic term birth, as proposed by the Liggins 
model [15]. For example, complete elimination of neutrophils and 
partial elimination of macrophages in mice does not block natural 
term birth [16]. Further, it has been shown that WBC infiltration, as 
well as the subsequent expression of pro-inflammatory factors in the 
cervix peak after, rather than, during pregnancy and that inconsistent 
or inaccurate tissue collection times in previous studies may have led to 
erroneous conclusions [16]. In light of these recent data, a new model 
has been proposed that places cervical epithelial cells as the initiator 
and mediator of cervical remodeling [15]. The new model suggest that 
the cervical epithelia secrete factors that cause slow structural changes 
in the maturity and organization of fibrillar collagen in the cervix and 
that decreased secretion of lysyl oxidase (LOX), the enzyme that cross-
links collagen molecules, leads to the softening of the cervix [17]. Fewer 
cross-links between collagen fibrils lead to fibrils of greater diameter, 
which increase the compliance of the tissue [10,11]. 
Here, we use proteomics, a proteome-wide technique, to identify 
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Abstract
Objective: Decipher mechanisms that underlie cervical remodeling (CR) during pregnancy. 
Design and population: Examine the proteomic profile of mice cervices in early and late pregnancy and verify data 
generated using Western Blot and real time PCR analysis. 
Main outcome measures: Identify signature proteins. 
Results: In total, seventy three (73) signature proteins were identified and were found up regulated in pregnancy, 
namely proteins associated with: a) collagen presence and organization (4), notably biglycan and lumican, b) immune 
scavenging functions and c) cytoskeletal activity. These proteomic trends were verified through Western blot and real 
time PCR analysis. 
Conclusion: These signature proteins and their expression profile collectively suggest a complex biological process 
involving extracellular matrix (ECM)- and immune`-associated factors. Based on these data, we propose that biglycan 
may provide the link between natural birth and inflammation-mediated pre-term birth.
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the signature proteins expressed in mice during early and late 
pregnancy. The generated proteomic data was verified by Western blot 
and real time PCR analysis. These findings point to further refinement 
of the concept that the cervical epithelial cells contribute to cervical 
remodeling and suggest a role for mechanical signaling in this process. 
Materials and Methods 
Animals used, surgeries and tissue harvest 
Pregnant (day 11 and 17) and non-pregnant mice sourced from 
Charles Rivers (C57BL6/129SvEv), were used in these studies (n=3-
5), as specified below. Ovariectomy was performed on non-pregnant 
animals in order to delineate proteins that are expressed in the absence 
of ovarian sex steroid hormones, thus subtracting the confounding 
effects of indigenous ovarian sex steroid hormones. Prior to tissue 
harvest, animals were euthanized by a lethal injection of Sodium 
Pentobarbital (Sleepaway®, Fort Dodge Laboratories Inc., Burlingame, 
CA) and perfused intra-cardially to flash out blood. Cervical tissues 
were carefully harvested under a stereomicroscope in order to exclude 
vagina and uterine tissues as much as is practical; processed and 
analyzed using proteomics analysis and the generated proteomics data 
were then verified using real time polymerase chain reaction (real time 
PCR’ n=5) and Western blot analysis (n=5). Specifically, non-pregnant 
ovariectomized (removal of ovaries) mice, as well as mice during day 
11 (early pregnancy) and day 17 (late pregnancy) of gestation were 
utilized. Surgeries (ovariectomy) for non-pregnant animals were 
performed as previously described [18,19]. All non-pregnant animals 
with normal uterine size, seven days after ovariectomy, were eliminated 
from the study. All experiments were performed in accordance with 
the Guide for the Care and Use of Laboratory Animals of the local 
institution (Appalachian State University) and the NIH guidelines 
(NIH publication number 86-23), and efforts were made to minimize 
both animal suffering and the number of animals used. 
Techniques used 
Protein expression studies: Proteomics and Western blot Analysis. 
All the key proteins (proteomics) expressed during the three selected 
physiological conditions (non-pregnant, early and late pregnancy) and 
two selected signature proteins from proteomics data (Western blot) 
were studied using proteomics and Western blot analysis, respectively, 
as described below. Tissues from the non-pregnant ovariectomized 
animals were used as negative control for baseline data.
General protein extraction (proteomics and western blot 
analysis): Total protein for proteomics and Western blot were extracted 
from whole cervical tissues using the protein inhibitor cocktail and 
cell lysis buffer from Sigma Aldrich (St Louis) and the supernatant was 
divided into half and immediately stored at -80°C. The core facility 
Laboratory of the David Murdock Research Institute (Kannapolis, 
NC) performed the proteomics analysis and selected proteins from the 
proteomics data were then verified by Western blot and real time PCR, 
described later below. 
Proteomics: 
Sample preparation: The samples were assayed using the Thermo 
Scientific Micro bicinchoninic acid (BCA) Protein Assay kit to determine 
protein concentration. The samples were diluted to fall within the linear 
working range of the kit (5-200 µg/mL) and the concentrations were 
calculated based on absorbance values compared to a bovine serum 
albumin (BSA) standard curve. The samples were filtered using a 3 kD 
ultra centrifugal filter to exchange the dissolution solvent with a mass 
spectrometry friendly buffer. 100 µL of sample was diluted to 500 µL 
with 50 mM ammonium bicarbonate and filtered. The samples viewed 
in Scaffold (Proteome Software, Portland, OR). QC and study samples 
were evaluated to confirm data quality. Liquid chromatography total 
ion current (TIC) outputs were assessed for signal quality and changes 
in signal intensity. Results were also monitored for signal trends, such 
as a consistent increase or decrease in TIC maximum values, and 
MASCOT search results were used to monitor the quality of the mass 
spectrometry (MS) data (Table 1). 
Western blot analysis: Quantitative analysis of protein expression 
for the following 2 selected signature proteins from the proteomics 
data was performed to verify and supplement proteomics analysis, as 
described previously (18, 19): a) Laminin γ-1 and b) Calcium-Activated 
Chloride Channel Regulator-1 (CLCA1). Membranes were stained with 
specific primary antibodies at 1: 500 dilution, washed several time prior 
to incubation with the secondary antibody, i.e., Donkey anti-rabbit 
IgG HRP conjugated and Streptactin HRP antibodies for 1 h at RT, 
and then washed again before incubating them with luminescence-
producing enzyme, namely limunol-enchancer/peroxidase solution 
and developed. Images were analyzed with ImageJ program (NIH). 
The specific bands of the proteins of interest were identified using a 
standard ladder with known molecular weight. 
Gene expression study: real time PCR: Gene expression analysis was 
performed using real time PCR to verify data generated by proteomics 
analysis, as described previously [18,19]. Specifically, based on the 
proteomics data, the mRNA expression of the following genes were 
System Parameter Setting
Autosampler Temperature 4°C
Injection 5.0 µL prepared sample
LC Trap Column Sample load time 5 min
Trap flow rate 5 µL/min
LC Analytical Column Column temperature 55°C
Flow rate 0.4 µL/min
Gradient Initial conditions: 98% A
t=60 min, 60% A
t=65 min, 5% A
t=70 min, 5% A
t=75 min, 98% A
t=95 min, 98% A
LTQ Orbitrap XL Mass 
Spectrometer
Experiment type Nth Order Double Play
# Dependent scans 5
Source voltage 2.0 kV
Capillary temperature 200°C
Source current 1.0 µA
Capillary voltage 47.0 V
Tube lens 100.0 V
FTMS survey scan time 1.0 sec
FTMS resolution 60,000
Survey time 90 min
Survey ion mode ES Mode
Survey polarity Positive
Survey mass range 375-2000
Activation type CID
Normalized collision energy 35.0
ITMS MS/MS mass range 50-2000
ITMS MS/MS scan time 0.2 sec
Table 1: LC and MS Instrument Parameters used in the study: Analytical sam-
ples were analyzed on a Thermo Scientific LTQ Orbitrap XL mass spectrometry 
system coupled to a Waters nano ACQUITY UPLC system using parameters pre-
sented in the Table below.
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selected and examined using real were rinsed with 200 µL ammonium 
bicarbonate and filtered. The tubes were inverted and centrifuged to 
collect the sample. A volume of each sample corresponding to 35 µg of 
protein (based on the protein quantization results) was used. The sample 
volumes were made equal by adding 50 mM ammonium bicarbonate 
(AmBic) to a volume of 29.8 µL. A 1% solution of Rapigest was added 
to each sample to denature the proteins and the mixture was placed in 
a shaking heated mixer at 40°C for 10 minutes. Disulfide bonds were 
reduced by adding 200 mM dithiothreitol (DTT) to each sample and 
the tubes were heated to 80oC for 15 minutes. Free sulfur atoms were 
alkylated with 400 mM Iodoacetamide (IA) by placing the tubes in the 
dark for 30 minutes at room temperature (RT). A tryptic digest was 
performed by adding 0.7 µg Gold-Mass Spectrometry grade trypsin 
to each tube and incubated overnight at 37°C. Alcohol dehydrogenase 
(ADH) digest from yeast was added to a final concentration of 50 fmol/
µg protein. The trypsin reaction was stopped and the Rapigest was 
degraded with the addition of 10% TFA/20% acetonitrile/70% water 
that was then heated to 60°C for 2 h. The samples were centrifuged and 
the supernatant pipetted into auto-sampler vials. 
A protein standard (BSA) was carried through the reduction/
alkylation and digestion steps and used as a quality control (QC) of 
the sample preparation steps and instrument performance. Liquid 
chromatography (LC) solvents for peptide separation included: a) 
water containing 0.1% formic acid; and b) acetonitrile containing 0.1% 
formic acid. The study sequence consisted of the study sample injections 
bracketed by a pair of QC injections. Data from all study samples were 
acquired using Data DependentTM scans (Nth order double play) on 
the LTQ Orbitrap XL. Database searches were performed in Elucidator 
(Rosetta Biosoftware) using MASCOT (Matrix Sciences, London, UK). 
Analytical results were also time PCR: a) Anterior Gradient Homolog-2; 
b) Calcium-Activated Chloride Channel Regulator-1 (CLCA1); c) 
Collagen 6α3 (COL6A3) and d) Laminin γ-1, using the same mice, i.e., 
strain and physiological conditions, described earlier. Gene expression 
analysis was performed in three steps, as described below. 
Statistical analysis 
Proteomics: Raw MS data files for the study samples, collected 
on the Thermo Orbitrap XL system, were processed in Elucidator. MS 
data were grouped in Elucidator based on sample group and alignment 
(Table 1). Sample groups were used to assist in data alignment, 
feature identification, and were utilized for QC assessment and group 
comparisons. Data were processed from retention time, 8-90 min. 
Thermo Orbitrap data files were searched using the Mascot search 
engine against the SwissProt mouse database (appended with yeast 
ADH, March 02, 2010). The aligned mass features were annotated with 
these database search results using the results from the system Peptide 
Tellers and a predicted error rate of 1%. MS data were summarized to 
the feature level, normalized, and an error-weighted ANOVA test was 
performed to compare the expression results between sample groups. 
Candidate differentially expressed markers were determined based on 
a p<0.01. Features were summarized by protein based on the results of 
the database search. Western blot and real time PCR: Data for Western 
 
Figure 1: An Example of Aligned Mass Data: An example of aligned peptide signals for the data set is presented here: a) Sample labels: Figures are color-coded 
according to sample group. Selection (red) references an option to manually select a single sample to be highlighted. This option was not selected; b) Top panel: 
Extracted ion chromatogram for m/z 840.719-842.439 from retention time 24.266-25.065 minutes demonstrates retention time alignment across all samples for this 
signal; c) Bottom panel: Aligned masses in the mass range of 840.733-842.416 for all samples in the study set.
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blot and real time PCR analyses were analyzed using Student’s t test 
and ANOVA, followed by Scheffe’s F-test for multiple comparisons. 
P-values of <0.05 were considered to be statistically significant. 
Results 
Protein expression studies 
Proteomics studies: 
Two hundred and six (206) proteins were identified in early and 
late pregnancy: Using the Rosetta Elucidator (Figure 1), a total of 206 
distinct proteins was identified in cervical tissues of ovariectomized 
non-pregnant and pregnant mice (early and late pregnancy) (Figure 2). 
Of these 206 identified proteins, 73 were variably-expressed proteins 
in the cervix (Figures 3-7). As for protein names and intensities), of 
which 15 proteins (out of 73 proteins) were up regulated during late 
pregnancy, relative to early pregnancy and baseline; 23 proteins were 
up regulated during early pregnancy, relative to late pregnancy and 
baseline (non-pregnant mice), while 35 proteins were up regulated in 
cervix from the non-pregnant mice relative that of the pregnant mice 
(Appendix A for complete list of each variably expressed protein, their 
gene name, intensities, errors and fold changes) (p<0.05). 
Proteins from diverse biological themes were variably expressed 
during pregnancy: Each of the variably expressed proteins was placed 
into a category based on its functions (Table 2). Biological categories 
were adapted from our previous DNA microarray publication [19]. 
Specifically, the following biological themes or processes (a-f) were up 
regulated in the cervix during pregnancy: a) protein kinase activity, 
b) proliferation, c) calcium binding, d) nucleus-related proteins, e) 
cytoskeleton-related proteins, f) extracellular matrix proteins (Table 
2), whereas, in contrast (g-i), proteins associated with g) tissue 
remodeling, h) circulation, and i) carbohydrate metabolism were found 
to be down regulated during pregnancy (Table 2) and, on the other 
hand, j) immune-related proteins and k) cellular adhesion proteins 
displayed unclear trends of expression (Table 2, see Appendix B for fold 
change associated with each specific protein). It is important to note 
that some of the proteins identified by the proteomics analysis do not 
have known functions and could not be placed into a specific group 
(Supplementary).
Specific expression patterns of selected proteins: Expression of 
specific selected proteins were found to be significantly up or down 
regulated in the cervix during pregnancy. Specifically, these proteins 
include: 1) Laminin, with a fold change of 147 between baseline and 
early pregnancy and a total fold change of 139 between baseline and late 
pregnancy (Figure 3); 2) calcium-activated chloride channel regulator, 
with a fold change of -58 between baseline and late pregnancy (Figure 
4); 3) anterior gradient protein 2, with a fold change of 999 between 
baseline (non-pregnant) and early pregnancy (Figure 5); and 4) 
indolethamine N-methyltransferase, with a fold change of 56 between 
baseline and late pregnancy (Figure 7B). Other target proteins included: 
a) collagen VI, with a fold change of 1.05 between baseline and early 
pregnancy and a total fold change of 15.8 between baseline and late 
pregnancy (Figure 6A); b) biglycan, with a fold change of 2.4 between 
baseline and early pregnancy and a fold change of 30.8 between baseline 
and late pregnancy (Figure 7A), c) lumican, with a fold change of -1.8 
between baseline and early pregnancy and a total fold change of -1.8 
between baseline and late pregnancy (Figure 7C); and d) vinculin, with 
a fold change of -1.8 between baseline and early pregnancy and a fold 
change of -1.2 between baseline and late pregnancy (Figure 7D). 
Western blot and Real time PCR studies: 
Laminin mRNA and protein expressions are pronounced during 
late pregnancy in mice cervix: Data generated from both Western 
blot and real time PCR for expression of laminin mRNA and protein 
in mice cervix indicate pronounced expression during late pregnancy 
compared to early pregnancy and non-pregnant mice, thus verifying 
the proteomic data (Figure 3). However, there was a significant 
difference in the intensity of expression for Western blot and real time 
PCR, compared to proteomics (Figures 3B and 3C). In contrast, for 
proteomics, differences in intensity between late pregnancy and early 
pregnancy/non-pregnancy states were in million fold, whereas they 
were only 2.5 and 1.67 fold more in late pregnancy compared to early 
pregnancy and non- pregnant mice, for Western blot and real time 
PCR, respectively (Figure 3). 
Levels of calcium-activated chloride channel regulator mRNA 
and protein rise during late pregnancy in mice cervix: Similar to 
expression of laminin mRNA and protein, the levels of calcium-
activated chloride channel regulator mRNA and protein in late 
pregnancy were greater than early pregnancy and the non-pregnant 
mice, as revealed by both Western blot and real time PCR analysis 
 
Figure 2: A distinct genome-wide protein expression profile in cervix of non-pregnant and pregnant mice: Cluster analysis reveal differentially expressed proteins 
of non-pregnant (Day 0), early pregnancy (Day 11) and late pregnancy mice cervices (Day 17), as determined by proteomics and analyzed by ANOVA analysis 
(n=3, p=0.05). 
Citation: Schwabe J, Donnelly SM, Jesmin S, Leppert P, Mowa CN (2014) A Proteomic Profile of Cervical Remodeling in Mice during Early and Late 
Pregnancy. J Steroids Horm Sci 5: 123. doi:10.4172/2157-7536.1000123
Page 5 of 9
J Steroids Horm Sci
ISSN: 2157-7536 JSHS an open access journal Volume 5 • Issue 1 • 1000123
(Figure 4B and 4C), thus again verifying the proteomic data (Figures 
4A). However, as was the case with laminin, there was a significant 
difference in the intensity of expression for Western blot and real 
time PCR (Figure 4B and 4C) compared to proteomics (Figure 4A). 
Differences in expression for proteomics between late pregnancy and 
early pregnancy/non-pregnancy states were tens of million folds, but 
only 2.5 and 1.67 fold for Western blot and about 3.0 and 1.5 folds for 
real time PCR more in late pregnancy than early pregnancy and non-
pregnant mice, respectively (Figure 4 B and C).
Anterior gradient protein 2 mRNA and protein expressions are 
up regulated in mice cervix in pregnancy: Overall, the expression 
of anterior gradient protein 2 mRNA and protein in mice cervix were 
found to be up regulated between gestational days 11 and 17 but not 
in non-pregnant mice, as revealed by proteomics and real time PCR 
(Figure 5). However, transcription levels in early pregnancy were lower 
than those of late pregnancy (Figure 5). No Western blot analysis was 
performed in this particular study. 
Expressions of collagen type VI, alpha 3 mRNA and protein 
significantly increase in mice cervix during pregnancy: Generally, 
levels of collagen type VI, alpha 3 mRNA in mice cervix during 
pregnancy increased sharply compared to non-pregnant mice by as 
much as about 40-110 fold, as revealed by real time PCR (Figure 6). 
This was the sharpest rise of transcription in all the studied genes. 
However, levels of transcription during early pregnancy were about less 
than half of late pregnancy (Figure 6B). Overall, both real time PCR and 
proteomics data showed trends of increased expressions of protein and 
mRNA during late pregnancy compared to non-pregnant mice (Figure 
6B). However, no difference was detected in collagen type VI, alpha 3 
protein expression between non-pregnant and early pregnant mice 
cervix, according to proteomics analysis (Figure 6). 
Discussion 
This study was designed to decipher the proteome-wide expression 
of the signature protein in the normal cervix of mice during early 
and late pregnancy compared to baseline (non- pregnant mice) using 
proteomics. We show here that various factors associated with cervical 
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Figure 3: Profile of laminin expression in the mice cervix during pregnancy, as 
revealed by proteomics (A), and verified by Western blot (B) and real time PCR 
(C). Overall, all the three techniques demonstrated increase in levels of laminin 
during late pregnancy compared to non- and early-pregnancy. (n=3 and 5 for 
proteomic and Western blot/real time PCR analyses, respectively; p<0.05 for 
NP/day 11 vs. day 17). 
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Figure 4: Calcium-Activated Chloride Channel Regulator (CLCAI) levels 
increase over pregnancy (early vs. late) in mice cervix, as revealed by proteomics 
(A), and verified by Western blot (B) and real time PCR (C). However, CLCAI 
mRNA levels in non-pregnant state were higher than early pregnancy and no 
difference was noted in Western blot analysis. (n=3; and 5 for proteomic and 
Western blot/real time PCR analyses, respectively; p<0.05 for Figure 3B, C: 
NP/day 11 vs. day 17and 3A: NP vs. day 11/17 and day 11 vs. day 17). 
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epithelia are variably expressed during pregnancy, such as immune, 
ECF and cytoskeletal factors. The present study adds credence to the 
recently proposed epithelia model of cervical modeling, both through 
the variable expression of specific cervical proteins and, overall, through 
the expression patterns of the different biological themes.
Generally, the most significantly and variably expressed proteins 
in the cervix in normal pregnancy were those involved in immune 
regulation and maintenance, cellular adhesion, the cytoskeleton and 
the key extracellular matrix factors. The immune system has been 
implicated in cervical remodeling for decades. The Liggins lab was 
the first to speculate in the 80s that cervical remodeling is essentially a 
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in mice cervix during pregnancy compared to non-pregnancy, as revealed by 
proteomics (A) and confirmed by real time PCR (B). No difference was noted 
in AGH-2 protein levels between early (day 11) and late (d 17) pregnancy (A). 
However, mRNA levels were lower in early compared to late pregnancy (B). 
(n=3 and 5 for proteomic and real time PCR analyses, respectively; p<0.05 
for  NP vs. day 11/day 17; Figure 4B: NP vs. day 11/17 and day 11 vs. day 17).
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Figure 7: Proteomic profile of various factors in cervices of non- and pregnant 
(early and late pregnancy) mice: A: Biglycan protein levels are significantly 
up-regulated in late pregnancy compared to non- and early- pregnancy (n=3, 
p=0.05, NP/day 11 vs. day 17); B: Indolethanmine N-methyltransferase protein 
levels are significantly diminished in during pregnancy in general compared to 
non-pregnancy (n=3, p=0.05, NP vs. day 11/17); C: Levels of lumican protein 
decrease by about×2 folds in during pregnancy compared to non-pregnancy 
(n=3, p=0.05, NP vs. day 11/17); D: Vinculin protein expression increases over 
pregnancy (early vs. late), but are lower than in cervix of non-pregnant mice 
(n=3, p=0.05, NP vs. day 11; day 11 VS. day 17). 
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physiological inflammatory-like response. It was proposed at that time 
that white blood cells infiltrate the cervix and secrete inflammatory 
factors and proteases that breakdown collagen and induce cervical 
remodeling, notably cervical softening and ripening [8], although that 
concept was challenged earlier on [9,10]. Other factors, such as mucous, 
secreted by the cervix, provide both a mechanical and chemical barrier 
against intrauterine infection [20]. Here, we identify eleven variably 
expressed proteins in mice cervices that are related to immune function, 
of which mucin 5b and calcium-activated chloride channel receptor 
were the most significantly up regulated. It is interesting to note that 
these two proteins, i.e., mucin 5b and calcium-activated chloride 
channel receptor, both play an important role in enacting the barrier 
(mucus plug) that prevents intrauterine microbial invasion. Mucins 
have also been shown to have similar immune functions in other 
“border” tissues, such as the bronchial epithelia [21,22]. These finding 
are consistent with previous proteomics studies on cervical mucus plug 
that suggested a role for the cervix as the first line of defense in infection 
and as an immune scavenger [23]. 
Biglycan  
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Figure 8: A novel proposed role and working model for biglycan. Biglycan provides a link between the natural- and inflammation-mediated cervical remodeling via 
its actions involving reorganizing collagen in the ECM and activating pro-inflammatory factors through TLR’s and NF-κB.
Protein functional 
biological theme
Number of proteins 
changing
Trend of protein 
expression in pregnancy
Protein kinase activity 2 Up regulated
Proliferation 9 Up regulated
Calcium binding 3 Up regulated
Tissue remodeling 4 Down regulated
Circulation 3 Down regulated
Immune-related proteins 11 Up regulated
Nucleus-related proteins 3 Up regulated
Cellular adhesion 3 Up regulated
Cytoskeleton-related 
proteins
17 Up regulated
Carbohydrate metabolism 3 Down regulated
Extracellular matrix 6 Up regulated
Heat shock proteins 1 Up regulated
Table 2: The biological themes are variably expressed in mice cervix during 
pregnancy (early and late) and in non-pregnant mice. Proteins were assigned to 
these groups based on function.
On the contrary, we also show here that a number of proteins that 
are associated with or promote inflammation and white blood cell 
activity were slightly down regulated in the cervix during pregnancy 
compared to non-pregnant mice. Specifically, these proteins include: 
a) macrophage migration inhibitory factor, which suppresses the anti-
inflammatory effects of glucocorticoids; b) galectin-1, which is secreted 
by epithelial cells and indirectly suppresses T cell function by inducing 
expression of IL-10 and IL-27; and c) elongation Factor 1-alpha, which 
increases T cell activity [24-27]. Collectively, these findings do not lend 
support to earlier suggestions of increased white blood cell activity 
during pre-softening (day 11) and ripening cervix (day 17), as proposed 
previously. Instead, it shows a possible involvement of epithelial activity 
since in other tissue types, each of these altered proteins are largely 
produced by epithelial cells, i.e., macrophage migration factor 1 in the 
bladder and major pelvic ganglia; galectin-1 in the thymus, thyroid and 
gut; and elongation factor-1 alpha in the ovaries, trachea and mammary 
glands [28-31]. Such observation and conclusion are consistent with 
recent reports that suggest that the cervical epithelia create an immune 
barrier that protects the uterine cavity from microbial invasion and 
infiltration during pregnancy [23]. Comprehensive studies on cellular 
immune-localization and bioassay activity will be essential in resolving 
this issue. 
The largest group of proteins identified in the present study was 
the cytoskeleton-related proteins. This cluster contains 17 mildly up-
regulated proteins (fold changes of less than 3), almost all of which 
bind or associate with actin. Such an expression profile or trend in this 
cluster of proteins (cytoskeleton and actin binding proteins) is novel 
in cervical remodeling studies, and as such, their specific roles in 
cervical remodeling are currently unclear. However, based on their key 
functions, i.e., proliferation and movement, and their role in mechano- 
transduction, we can speculate that they are likely involved in cervical 
growth, which is a prominent feature induced by relaxin during cervical 
remodelling [16,32]. Interestingly, we have recently shown that VEGF 
also stimulates genome-wide expression of proliferation- and adhesion-
related genes and induces marked growth of cervical epithelial cells 
[18,19] and, in other tissues, it (VEGF) has been shown to modulate 
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the adhesion and key set of cytoskeletal regulatory molecules, the 
Rho GTPases, and ultimately, cytoskeletal growth and activity. 
These molecules (Rho GTPases) are known to direct several steps in 
morphogenesis, which notably include epithelial cell (EC) motility, 
alignment, multi-cellular organization, as well as intercellular junction 
integrity [33,34]. The possible involvement of relaxin and VEGF in 
regulating cytoskeletons and proliferation in the cervix and their 
collective impact on cervical remodeling will be worth investigating 
in the future. Vinculin, which was increased in the cervices of mice in 
late gestation compared to early pregnancy, is a component of cell-cell 
and cell-matrix adhesions and is an important scaffold protein involved 
in mechano-transduction pathways [35-37]. Cervical growth in 
pregnancy is influenced by increased water as well, which also affects the 
mechanical forces on this tissue [38]. Therefore, the effect of mechanical 
forces on cervical biochemical changes is also ripe for study. Of note, 
we identify here a cluster of extracellular matrix proteins that play a 
critical role in maintaining the biomechanical integrity of the cervix, 
as well as cervical remodeling, in general. As expected, proteins in this 
cluster were robustly up regulated during pregnancy, with an average 
fold change of +29.87 between non-pregnant and early pregnancy states 
and a similar trend between early and late pregnancy, suggesting an 
important function for this group in maintaining cervical remodeling 
during normal pregnancy. For instance, laminin, a protein found 
mainly in the basal lamina surrounding blood vessels and separating 
the epithelial cells, was variably expressed during pregnancy, including 
two types of collagen (Collagen I and VI) [39]. While collagen I is the 
primary type of collagen present in the cervix, collagen VI, whose 
different chains accounts for three of the eight proteins in the ECM 
group, has not been previously reported in the cervix [10]. This collagen 
type (VI) is primarily found in the basal lamina and, of relevance to the 
present study, is efficiently bound by short leucine-rich proteoglycans 
(SLRP’s) [40,41]. Of the total eight proteins identified in the ECM 
cluster, two are SLRP’s, i.e., biglycan and lumican, both of which can 
bind and reorganize collagen VI and I into fibrils [40,42]. However, 
while biglycan was found to be significantly up regulated during 
pregnancy, lumican was, in contrast, down regulated, suggesting that 
biglycan may play an important role in manipulating cervical collagen 
during pregnancy. Such a speculation is consistent with previous data 
that have shown biglycan to have pronounced influence on collagen I 
and VI reorganization and that collagen fibrils become more organized 
later in pregnancy [17]. Further, it is likely that biglycan and, perhaps 
decorin [18,43], may be involved in collagen reorganization into large, 
spaced out fibrils that lead to enhanced cervical softening, and that 
this process could be facilitated by a decrease in the expression of lysyl 
oxidase, the enzyme that is known to cross-link collagen molecules and 
create a dense network of thin collagen fibrils [1]. 
While biglycan is known to be an efficient regulator of collagen 
organization, in some tissues, it has also been implicated in inflammatory 
responses [44]. If such a dual role holds true or exists in the cervix, it 
is feasible to speculate that biglycan and other molecules with similar 
dual effects, such as VEGF [18,45], may provide the link between the 
abnormal inflammation- related and normal or physiological cervical 
remodeling, through their involvement in both ECM organization and 
inflammation. Interestingly, biglycan is also necessary for pregnancy 
to be carried to term in mice [46]. Specifically, biglycan enhances 
inflammation by binding to and activating toll-like receptors 2 and 4 
(TLR2, TLR4), which are receptors for lipopolysaccharide (LPS), the 
endotoxin of Gram-negative bacteria located in the outer membrane, 
and responsible for eliciting strong immune responses. These receptors 
are expressed in both cervical epithelia and macrophages, cell types 
that notably are present in significant numbers in the cervix during 
pregnant [44-49]. The TLR molecules, in turn, activate the master 
transcription factor of inflammation, namely NFκB, which induces the 
transcription of many classical pro- inflammatory genes. Importantly, 
biglycan production is also known to be induced by activated 
NF-κB signaling pathway and by IL-6, a pro-inflammatory cytokine 
downstream of NF-κB [49], suggesting a likely existence of a positive-
feed forward mechanism in extra-cervical tissues. If such a loop exists 
in the remodeling cervix, it may possibly help explain the link between 
the two competing models of cervical remodeling, i.e., the expression of 
biglycan in normal cervical remodeling is up regulated, leading to the 
reorganization of collagen in the ECM of the cervix. Whereas, during 
infection-mediated cervical remodeling, increased levels of biglycan 
enhances inflammation by activating TLR and molecules downstream 
of it, such as NFκB and pro-inflammatory factors. Preliminary data from 
on-going studies in our lab support this alternative model. However, it 
is important to note that more work is required to rigorously test the 
proposed model. 
It is important to note that the 206 proteins identified here are, 
without a doubt, far less than the actual total number of proteins 
expressed in the cervix during pregnancy, perhaps reflecting the 
limitations in the sensitivity of the LC/MS/MS procedure of label-
free proteomics compared to other genome-wide techniques. It 
is also possible that expression of the less abundant proteins were 
overshadowed by those of the dominant fibrous elements of the cervix, 
which are about 80% of the tissue. This is the major limitation of the 
present study. Secondly, there were a few instances when trends in the 
proteomic data were not perfectly verified by Western and real time 
data. A recent review by Vogel and Marcotte (2012) provides insights 
into the correlation of proteomics, gene and protein expression, and 
states that these correlations can be as little as 40%, depending on the 
system [50]. Lastly, as in all previously published studies in this field, it 
is possible that vaginal and uterine tissues, as well as blood components, 
may not have been excluded completely during cervical tissue harvest, 
even though great care was taken to prevent tissue contamination 
during this process. 
In conclusion, we show here that cervical epithelial-associated 
factors, such as those involved in immune regulation, ECM organization 
and cytoskeletal activities, are active during normal pregnancy, 
suggesting a role for cervical epithelia in normal cervical remodeling. 
Additionally, we propose a new model and additional role for biglycan 
in the cervix, i.e., it may provide the link between the pathological 
inflammation-induced and the physiological cervical remodeling 
(Figure 8). This model remains to be tested. 
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